KINTARA THERAPEUTICS INC (KTRA) Stock Analyst Ratings
USA - NASDAQ:KTRA - US49720K2006 - Common Stock
0.2154 USD
-0.01 (-6.31%)
0.225 USD
+0.01 (+4.46%)
ChartMill assigns a Buy % Consensus number of 43% to KTRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.28. This target is 6529.53% above the current price.
KTRA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about KTRA.
In the previous month the buy percentage consensus was at a similar level.
KTRA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-07-14 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-09-29 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-05-16 | Dawson James | Downgrade | Buy -> Neutral |
| 2022-01-20 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-30 | Aegis Capital | Maintains | Buy |
| 2021-09-28 | HC Wainwright & Co. | Initiate | Buy |
KINTARA THERAPEUTICS INC / KTRA FAQ
What is the price target for KTRA stock?
6 analysts have analysed KTRA and the average price target is 14.28 USD. This implies a price increase of 6529.53% is expected in the next year compared to the current price of 0.2154.
What is the consensus rating for KINTARA THERAPEUTICS INC (KTRA) stock?
The consensus rating for KINTARA THERAPEUTICS INC (KTRA) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.